Creo Medical Group (LSE:CREO) FCF Margin % : -49.67% (As of Dec. 2023)

View and export this data going back to 2016. Start your Free Trial

What is Creo Medical Group FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Creo Medical Group's Free Cash Flow for the six months ended in Dec. 2023 was £-7.50 Mil. Creo Medical Group's Revenue for the six months ended in Dec. 2023 was £15.10 Mil. Therefore, Creo Medical Group's FCF Margin % for the quarter that ended in Dec. 2023 was -49.67%.

As of today, Creo Medical Group's current FCF Yield % is -18.18%.

The historical rank and industry rank for Creo Medical Group's FCF Margin % or its related term are showing as below:

LSE:CREO' s FCF Margin % Range Over the Past 10 Years
Min: -99769.23 Med: -127.71 Max: -75.32
Current: -75.32

During the past 9 years, the highest FCF Margin % of Creo Medical Group was -75.32%. The lowest was -99769.23%. And the median was -127.71%.

LSE:CREO's FCF Margin % is ranked worse than
74.34% of 830 companies
in the Medical Devices & Instruments industry
Industry Median: -7.41 vs LSE:CREO: -75.32

Creo Medical Group FCF Margin % Historical Data

The historical data trend for Creo Medical Group's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Creo Medical Group FCF Margin % Chart

Creo Medical Group Annual Data

Trend

Feb14

Feb15

Feb16

Jun17

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Margin %

Get a 7-Day Free Trial

-99,769.23

-178.77

-127.71

-104.27

-75.32

Creo Medical Group Semi-Annual Data
	Feb14	Feb15	Feb16	Dec16	Jun17	Dec17	Jun18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
FCF Margin %	Get a 7-Day Free Trial												-154.45	-137.50	-70.96	-100.00	-49.67

Competitive Comparison of Creo Medical Group's FCF Margin %

For the Medical Devices subindustry, Creo Medical Group's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Creo Medical Group's FCF Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Creo Medical Group's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Creo Medical Group's FCF Margin % falls into.

Creo Medical Group FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Creo Medical Group's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-23.2	/	30.8
	=	-75.32 %

Creo Medical Group's FCF Margin for the quarter that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	-7.5	/	15.1
	=	-49.67 %

Creo Medical Group FCF Margin % Related Terms

Thank you for viewing the detailed overview of Creo Medical Group's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Creo Medical Group (LSE:CREO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Creo Medical Group PLC (LSE:CREO) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Beaufort Park Way, Unit 2, Creo House, Beaufort Park, Chepstow, GBR, NP16 5UH

Website

https://www.creomedical.com

Creo Medical Group PLC is a medical device company engaged in providing services in the field of surgical endoscopy. The company has developed a platform called Croma which is an electrosurgical platform to deliver microwave and bipolar radiofrequency through a single accessory port. The reportable segment of the company is the research and development of electrosurgical medical devices relating to the field of surgical endoscopy.

Creo Medical Group (LSE:CREO) Headlines

No Headlines